| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3K | -37.0% |
| Cost of Revenue | $280 | -78.3% |
| Gross Profit | $3K | -23.9% |
| R&D Expense | $192K | +248.1% |
| SG&A Expense | $547K | -10.8% |
| Operating Income | -$1.2M | +5.4% |
| Pre-tax Income | -$1.3M | +3.2% |
| Net Income | -$1.3M | +3.2% |
| EPS (Basic) | -$0.01 | +0.0% |
| EPS (Diluted) | -$0.01 | +0.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Current Assets | $18K | -58.9% |
| Total Assets | $1.3M | +4.4% |
| Current Liabilities | $2.9M | +42.7% |
| Total Liabilities | $4.2M | +31.1% |
| Stockholders' Equity | -$2.9M | -47.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$271K | -87.3% |
| Investing Cash Flow | -$231K | +5.3% |
| Financing Cash Flow | $507K | +20.0% |